But with Novartis failing to convince European regulators about the merits of Xiidra last year, and Allergan's ageing Restasis potentially facing generic competition, there’s a lot to play for ...

As on 30-09-2024, the company has a total of 55.37 Crore shares outstanding.Generic Pharmasec Share Price Today is Rs. 3.11 as on 06 Jan, 2025, 03:56 PM IST. On previous day, the Generic Pharmasec ...